About Integer Holdings Corporation Common Stock (ITGR)
Integer Holdings Corp is a leading provider of advanced medical devices and components, specializing in the design and manufacture of innovative solutions for the healthcare industry. The company focuses on developing products that support critical therapeutic and diagnostic applications, catering to a diverse range of medical markets including cardiovascular, orthopedics, and neuromodulation. Integer's expertise encompasses a variety of technologies, enabling it to deliver high-quality, reliable medical products that enhance patient outcomes and drive advancements in healthcare. Through strategic partnerships and a commitment to innovation, Integer Holdings Corp plays a vital role in improving lives and expanding the possibilities of medical technology. Read More
Wall Street’s bearish price targets for the stocks in this article signal serious concerns.
Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
Shares of medical technology company Integer Holdings (NYSE:ITGR)
jumped 3.4% in the morning session after the company reported better-than-expected fourth-quarter 2025 results and provided an encouraging profit forecast for the upcoming year.
Medical technology company Integer Holdings (NYSE:ITGR) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 5% year on year to $472.1 million. The company expects the full year’s revenue to be around $1.85 billion, close to analysts’ estimates. Its non-GAAP profit of $1.76 per share was 3.6% above analysts’ consensus estimates.
Shares of medical technology company Integer Holdings (NYSE:ITGR)
jumped 4.2% in the morning session after the company reported better-than-expected fourth-quarter 2025 revenue and earnings, alongside encouraging profit guidance for the upcoming year. The medical device manufacturer's fourth-quarter revenue grew 5% year-over-year to $472.1 million, surpassing Wall Street's estimates. Its adjusted earnings per share (EPS) of $1.76 also beat expectations and marked a 23% increase from the same period in the prior year. Looking ahead, Integer provided an adjusted EPS forecast for 2026 with a midpoint of $6.54, which was 3.8% above analysts' projections. This strong profit outlook likely overshadowed a weaker forecast for flat revenue growth, giving investors reason for optimism.
Medical technology company Integer Holdings (NYSE:ITGR) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 5% year on year to $472.1 million. The company expects the full year’s revenue to be around $1.85 billion, close to analysts’ estimates. Its non-GAAP profit of $1.76 per share was 3.6% above analysts’ consensus estimates.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Integer (ITGR) To Contact Him Directly To Discuss Their Options
Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of common stock of Integer Holdings Corporation (NYSE: ITGR) between July 25, 2024 and October 22, 2025. Integer is a medical device contract manufacturer.
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Integer Holdings Corporation (“Integer” or the “Company”) (NYSE: ITGR), if they purchased or otherwise acquired the Company’s shares between July 25, 2024 and October 22, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Integer (ITGR) To Contact Him Directly To Discuss Their Options
The Law Offices of Frank R. Cruz reminds investors of the upcoming February 9, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Integer Holdings Corporation (“Integer” or the “Company”) (NYSE: ITGR) common stock between July 25, 2024 and October 22, 2025, inclusive (the “Class Period”).
